Steve Schonfeld’s Aardvark Therapeutics AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$84K Buy
+15,942
New +$97.3K ﹤0.01% 2508
2026
Q1
– Sell
-50,131
Closed -$658K – 2786
2025
Q4
$658K Sell
50,131
-203,621
-80% -$2.54M ﹤0.01% 1284
2025
Q3
$3.37M Sell
253,752
-25,506
-9% -$288K 0.02% 776
2025
Q2
$3.78M Buy
279,258
+135,307
+94% +$1.39M 0.03% 672
2025
Q1
$1.08M Buy
+143,951
New +$1.62M 0.01% 1255

Other funds holding AARD

Steve Schonfeld's AARD Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Aardvark Therapeutics (AARD) in Q3 2026: 15,942 shares worth $84K. The stake represents ﹤0.01% of the portfolio and ranks #2508 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in AARD as recently as Q4 2025.

Steve Schonfeld first reported a position in AARD in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.78M in Q2 2025. 76 funds tracked by Wall St. Rank hold AARD as of Q3 2026.

  • Steve Schonfeld held 15,942 shares of Aardvark Therapeutics worth $84K as of Q3 2026.
  • Aardvark Therapeutics was a new Steve Schonfeld position in Q3 2026.
  • Aardvark Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2508 holding.
  • Steve Schonfeld first reported a position in Aardvark Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Steve Schonfeld's Aardvark Therapeutics position peaked at $3.78M in Q2 2025.
  • 76 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.